ChiRex elects Dr. Dirk Detert to its board of directors.MARLBOROUGH, Mass.--(BUSINESS WIRE)--May 6, 1996 -- ChiRex Inc. (Nasdaq: CHRX) announced today the election of Dr. Dirk Detert to its Board of Directors. Dr. Detert, 55, is the former General Manager of Wellcome GmbH with responsibility for Central Europe Central Europe is the region lying between the variously and vaguely defined areas of Eastern and Western Europe. In addition, Northern, Southern and Southeastern Europe may variously delimit or overlap into Central Europe. and a Managing Director of Germany. He is a former Member of the Board of the German Pharmaceutical Association and the German Chemical Association. Dr. Detert holds a Ph.D. in Chemistry from the University of Alberta, Edmonton, Canada and a Bachelor of Science Noun 1. Bachelor of Science - a bachelor's degree in science BS, SB bachelor's degree, baccalaureate - an academic degree conferred on someone who has successfully completed undergraduate studies in Chemistry from the University of Kiel The University of Kiel (German Christian-Albrechts-Universität zu Kiel, CAU) is a university in the city of Kiel, Germany. It was founded in 1665 as the Academia Holsatorum Chiloniensis . "Dr. Detert brings to ChiRex a remarkable breadth of experience in chemical and pharmaceutical product development, sales, marketing, and management," said Dr. Robert L. Bratzler, ChiRex's Chairman and Chief Executive Officer. "Dirk's experience will be especially valuable to ChiRex s joint venture, InNova Pharmaceuticals, as it positions itself to sell formulated generic drugs generic drug, a drug sold or prescribed under the nonproprietary name of its active ingredients or under a generally descriptive name rather than under a brand or trade name. around the world. His 26 year career in the pharmaceutical industry includes acting as General Manager Pharma for Hoechst Mexico and Hoechst Columbia. ChiRex, through its joint venture, InNova Pharmaceuticals, has begun to ship its first pharmaceutical product, paclitaxel paclitaxel /pac·li·tax·el/ (pak?li-tak´sel) an antineoplastic that promotes and stabilizes polymerization of microtubules, isolated from the Pacific yew tree (Taxus brevifolia); , to Argentina and intends to sell paclitaxel in as many as 10 countries before the end of 1997." ChiRex Inc. specializes in the development, manufacture and marketing of pharmaceutical fine chemicals and, through its joint venture, InNova Pharmaceuticals, formulated generic drugs. ChiRex currently produces over 50 pharmaceutical chemicals in its world-class cGMP manufacturing facilities and has a product development pipeline of more than 15 products using its patented ChiRedox process technologies. -0- ChiRex Inc. will move to new corporate offices on May 9, 1996: 65 William Street William Street may refer to:
CONTACT: ChiRex Robert L. Bratzler, Ph.D. or Michael A. Griffith (508) 460-1212 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion